ATTOVIA Trademark

Trademark Overview

On Monday, July 13, 2026, a trademark application was filed for ATTOVIA with the United States Patent and Trademark Office. The USPTO has given the ATTOVIA trademark a serial number of 99937656. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, July 13, 2026. This trademark is owned by Attovia Therapeutics, Inc.. The ATTOVIA trademark is filed in the Pharmaceutical Products category with the following description:

Biotherapeutics, namely, pharmaceutical preparations for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, pain, respiratory diseases, gastrointestinal diseases, cancer, diseases of the central nervous system, neurological and psychiatric disorders, neurodegenerative diseases, infectious diseases; Biotherapeutics, namely pharmaceutical preparations for the treatment of livestock diseases, namely, allergy, immune and inflammatory diseases, metabolic diseases, pain, respiratory diseases, gastrointestinal diseases, cancer, diseases of the central nervous system, neurological and psychiatric disorders, neurodegenerative diseases, and infectious diseases
attovia

General Information

Serial Number99937656
Word MarkATTOVIA
Filing DateMonday, July 13, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, July 13, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiotherapeutics, namely, pharmaceutical preparations for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, pain, respiratory diseases, gastrointestinal diseases, cancer, diseases of the central nervous system, neurological and psychiatric disorders, neurodegenerative diseases, infectious diseases; Biotherapeutics, namely pharmaceutical preparations for the treatment of livestock diseases, namely, allergy, immune and inflammatory diseases, metabolic diseases, pain, respiratory diseases, gastrointestinal diseases, cancer, diseases of the central nervous system, neurological and psychiatric disorders, neurodegenerative diseases, and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 13, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAttovia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Carlos, CA 94070
US

Trademark Events

Event DateEvent Description
Monday, July 13, 2026NEW APPLICATION ENTERED
Monday, July 13, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 13, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

attovia diseases namely system nervous central cancer neurological psychiatric infectious neurodegenerative